Fundraising FoxAuriga Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Exeliom Biosciencesexeliombio.cominJul 2023
Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis).
BiotechDeep TechDigital HealthMedical DevicesParis, FR
Harry Sokol(Scientific Co-founder)in
Co-investorsBpifranceAgoranovForepont Capital PartnersUI Investissement
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.